- Open Access
Clinical application prospect of umbilical cord-derived mesenchymal stem cells on clearance of advanced glycation end products through autophagy on diabetic wound
© The Author(s) 2017
- Received: 12 December 2016
- Accepted: 17 March 2017
- Published: 24 March 2017
Nowadays, wound healing delay due to diabetes is considered to be closely related to the accumulation of advanced glycation end products (AGEs). Although mesenchymal stem cells (MSCs) exhibit positive effects on diabetic wound healing, related mechanisms are still not fully elucidated. It has been reported that MSCs can improve the activity of autophagy in injured tissues, thereby playing an important role in wound healing. The autophagy induced by MSCs may be beneficial to diabetic wound healing via removing AGEs, which provide new ideas for clinical treatment of diabetic wounds with the potential of broad application prospects. In this study, the current research situation and application prospect of umbilical cord-derived MSCs on the clearance of AGEs in diabetic wound were reviewed.
- Mesenchymal stem cells
- Diabetic wound
- Advanced glycosylation end products
- Wound healing
Currently, the incidence of diabetes is increasing year by year. A high morbidity of diabetic foot ulcers (more than 25%) is always found in diabetic patients . As a common complication of diabetes, chronic diabetic wounds with the characteristics of low cure rate and high amputation rate not only causes great pain to patients, but also increases the burden of the family and society. Despite the existing therapy methods, there are still no effective therapy measures available for the treatment of diabetic wounds owing to its complex mechanisms and characteristics. Therefore, it is urgent to search for new approaches to promote wound healing in diabetic patients.
The mechanisms of diabetic wound healing are complicated. It has been shown that the mechanisms of diabetic wound healing are associated with various factors, including ischemia and hypoxia, abnormal inflammatory response, excessive microbial load, peripheral neuropathy, and abnormal expressions of matrix metalloproteinases and vascular endothelial growth factors. However, clear mechanisms of diabetic wound healing have not been fully clarified. With the deepening study on pathogenesis of diabetic skin lesions, advanced glycation end products (AGEs) have been revealed to be closely related to the delayed healing of diabetic skin wounds . AGEs are the final products of non-enzymatic catalytic reaction of amino (proteins, lipids, and nucleic acids) and aldehyde groups of carbohydrate under continuous high level of glucose conditions. In patients with diabetes, pathologic high blood glucose could always accelerate the glycosylation reaction, thereby producing a large amount of AGEs. However, the accumulation of AGEs cannot be recovered to normal level by reducing blood glucose. AGEs, as the direct products of diabetic metabolic remodeling, are an important environmental medium for changes of skin tissue cells, extracellular matrix, and cytokines. Therefore, accumulation of AGEs could induce the occurrence of damaged skin in diabetic patients. Besides, AGEs also exhibit the ability to inhibit fibroblast differentiation, proliferation, and migration, which could delay the process of wound healing through decreasing the expression of collagen . Some animal experiments have suggested that the application of anti-AGE agents could promote the healing of soft tissue wounds . Although the accumulation of dermal AGEs has been considered as a fundamental cause of diabetic wound formation or refractory healing, only few effective methods have been revealed to be able to inhibit and remove AGEs in the wound so far [5, 6].
Recently, some positive effects of cathepsins on clearance of AGEs were revealed in vivo. Reported as follows, Grimm et al.  have demonstrated that cathepsin D plays an important role in the degradation of intracellular AGEs. Meanwhile, a further investigation of them has also shown that both cathepsin D and L have significant positive roles in the reducing of toxicity caused by AGEs . Moreover, phytopharmaceutical Dispo85E is also reported having the ability to remove AGEs through the autophagy-lysosomal pathway induced by hepatocyte growth factor both in vivo and in vitro . As an important protective mechanism in eukaryotic cells, autophagy plays a crucial role in the maintaining of homeostasis in the intracellular environment. During this process, autophagosome is firstly formed by packaging the cytoplasmic proteins and organelles into a double membrane, and then combined to the lysosome to form an autolysosome. Based on this autolysosome, the expressions of cathepsins will be obviously induced in lysosome, while the activity of lysosome is activated. Since autophagy is able to degrade toxic protein aggregation, damaged mitochondria, and other cellular organelles in cells , the accumulation of AGEs, a production of glucose metabolism, may also be removed by autophagy/cathepsin pathway. Nowadays, several small-molecule activators involved in autophagy pathways such as rapamycin, trehalose, lithium, and rilmenidine have been identified to be able to up-regulate autophagy activity and promote the degradation of the polyproteins. However, the application of these factors is still limited in the clinical setting. For example, the common autophagy inducer rapamycin is a major regulatory protein in insulin signaling pathway, which could also influence many other metabolic pathways. Meanwhile, the autophagy induction process of rapamycin is relatively slow with a long indirect acting time, and the effects of rapamycin were always temporary . Therefore, searching for new ideal autophagy inducer exhibited important application values in the clinical setting.
Until now, there are still some patients with diabetic wound failed to cure in spite of continuous development on the treatment technology of diabetic wounds . Recently, the advent of stem cell therapy, which is considered to be the basis of tissue regeneration, has brought great hope to these diabetic patients . Mesenchymal stem cells (MSCs) are a kind of tissue stem cells with multiple differentiation potential, which are initially found in bone marrow. The promotion effect of different sources of MSCs on diabetic wound healing has been investigated by several researchers. Local application of allogeneic bone marrow-derived MSCs could promote wound healing in diabetic rats . Meanwhile, adipose tissue and hair follicle dermal sheath-derived MSCs are also beneficial to chronic wound healing in patients with diabetes [15, 16]. Moreover, compared with bone marrow-derived MSCs, umbilical cord-derived MSCs (UCMSCs) possess better biological characteristics such as easy obtainability, rich source, no ethical problems, and strong proliferation potential and show effective promotion effect on wound healing of skin ulcer in patients suffered with type 2 diabetes . Further research has indicated that positive effects of UCMSCs on wound healing were associated with differentiation into keratinocyte and release of ICAM-1, TIMP-1, and VEGF-A . Although the accumulation of AGEs has been identified to be one of the fundamental causes of impaired wound healing in diabetes , the scavenging effects of UCMSCs on AGEs and its related molecular mechanism are still elucidated.
Preliminary results on the relations between autophagy and wound healing have been shown by various studies. As reported, the expression of autophagy-related gene Beclin-l in burn wound was significantly increased, and increased autophagy was found to be helpful to wound healing . However, excessive autophagy could induce apoptosis and result in delay in wound healing . In addition, similar to apoptosis and necrosis, autophagy also serves a vital role in the process of deepening wound [21, 22]. It has been reported that adenosine could promote wound healing of diabetic ischemic ulcers through improving autophagy of endothelial progenitor cells . MSC transplantation was beneficial to carbon tetrachloride-induced liver regeneration and survival of pulmonary epithelial cells in acute lung injury through autophagy upregulation [24, 25]. MSCs are also considered to be able to alleviate beta cell damage induced by chronic high glucose via regulation of autophagy both in vivo and vitro . All the above researches have illustrated that enhanced autophagy activity is favorable in the regeneration and reparation of injured tissue cells. On the other hand, MSCs are also reported being able to activate autophagy, thereby removing intracellular accumulation of toxic proteins and increasing the viability and survival of neurons . Meanwhile, MSC-induced autophagy could also remove abnormal proteins or amino acids in vivo and promote cell repair. However, the mechanisms and promotion effects of MSCs on autophagy activity and scavenging capacity in diabetic wounds are still unclear. Hence, research on the clearance effects of autophagy induced by MSC transplantation in wounds and its related molecular mechanism will become a hot topic and urgently need to be concerned.
Diabetic wounds are not only accompanied by the accumulation of high glucose and AGEs, but also associated with ischemia and hypoxia. Under anoxic condition, the dissociation of Beclin-1 from Bcl-XL and Bcl-2 could be induced by activated hypoxia-inducing factor 1α (HIF-1α) through upregulated BNIP3, and then the released Beclin-l could promote autophagy via serving as a positive regulator in this procedure. HIF-1α/BNIP3/Beclin-1 has been considered to be an important signaling pathway in the upregulation of autophagy under hypoxia . The expression of HIF-1α is significantly reduced in diabetic skin wounds , while MSCs have been found to promote wound healing through upregulating HIF-1α in fibroblast cells . Therefore, we suspected that the wound healing might be improved by MSC transplantation-induced autophagy via the HIF-1α/BNIP3/Beclin-1 pathway and the clearance of AGEs through autophagy/cathepsin.
To sum up, autophagy/cathepsin is able to enhance cell viability and proliferation ability through clearance of intracellular AGEs. As a new approach to promote wound healing, UCMSC application has certain safety and no side effects, as well as a good ability in clearing AGEs via enhancing autophagy; therefore, UCMSCs may become an ideal autophagy inducer in the promotion of wound healing and provide new ideas and strategies for the treatment of diabetic wound healing in the clinical setting. However, the popularization and application of further clinical research findings are still required to further confirm the effects of this method in increasing wound healing rate, reducing amputation rate, hospital stay and costs, relieving the pain and improving the life quality of diabetic patients with chronic wounds, as well as reducing the burden of family and society. At present, with a high prevalence of diabetes, the rate of diabetic patients complicated with chronic ulcer wound is grown to 25%. The clinical application of UCMSCs in the treatment of diabetic wounds will bring out the significant economic and social benefits with a broad prospective.
YH and TS carried out the literature search and drafted the manuscript. RT reviewed the manuscript and corrected language and grammar. YH coordinated and helped to draft the manuscript. JL served as the final internal reviewer. All authors read and approved the final manuscript.
The authors declare that they have no competing interests.
Consent for publication
All authors consent for publication.
Ethics approval and consent to participate
This article does not contain any studies with human participants or animals performed by any of the authors.
This study was funded by Beijing Nova Program (No. Z1511000003150128) and Science and Technology Special Fund for Social Development of Hainan (2015SF45).
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
- Wang R, Feng Y, Di B. Comparisons of negative pressure wound therapy and ultrasonic debridement for diabetic foot ulcers: a network meta-analysis. Int J Clin Exp Med. 2015;8(8):12548–56.PubMedPubMed CentralGoogle Scholar
- Nazaruk J, Borzym-Kluczyk M. The role of triterpenes in the management of diabetes mellitus and its complications. Phytochem Rev. 2015;14(4):675–90.View ArticlePubMedGoogle Scholar
- Pepe D, Elliott CG, Forbes TL, Hamilton DW. Detection of galectin-3 and localization of advanced glycation end products (AGE) in human chronic skin wounds. Histol Histopathol. 2014;29(2):251–8.PubMedGoogle Scholar
- Chang PC, Tsai SC, Jheng YH, Lin YF, Chen CC. Soft-tissue wound healing by anti-advanced glycation end-products agents. J Dent Res. 2014;93(4):388–93.View ArticlePubMedGoogle Scholar
- Niu Y, Cao X, Song F, Xie T, Ji X, Miao M, Dong J, Tian M, Lin Y, Lu S. Reduced dermis thickness and AGE accumulation in diabetic abdominal skin. Int J Low Extrem Wounds. 2012;11(3):224–30.View ArticlePubMedGoogle Scholar
- Tian M, Qing C, Niu Y, Dong J, Cao X, Song F, Ji X, Lu S. The relationship between inflammation and impaired wound healing in a diabetic rat burn model. J Burn Care Res. 2016;37(2):e115–24.View ArticlePubMedGoogle Scholar
- Grimm S, Ernst L, Grötzinger N, Höhn A, Breusing N, Reinheckel T, Grune T. Cathepsin D is one of the major enzymes involved in intracellular degradation of AGE-modified proteins. Free Radic Res. 2010;44(9):1013–26.View ArticlePubMedGoogle Scholar
- Grimm S, Horlacher M, Catalgol B, Hoehn A, Reinheckel T, Grune T. Cathepsins D and L reduce the toxicity of advanced glycation end products. Free Radic Biol Med. 2012;52(6):1011–23.View ArticlePubMedGoogle Scholar
- Peng KY, Horng LY, Sung HC, Huang HC, Wu RT. Hepatocyte growth factor has a role in the amelioration of diabetic vascular complications via autophagic clearance of advanced glycation end products: Dispo85E, an HGF inducer, as a potential botanical drug. Metabolism. 2011;60(6):888–92.View ArticlePubMedGoogle Scholar
- Lu K, Psakhye I, Jentsch S. Autophagic clearance of polyQ proteins mediated by ubiquitin-Atg8 adaptors of the conserved CUET protein family. Cell. 2014;158(3):549–63.View ArticlePubMedGoogle Scholar
- Klionsky DJ, Meijer AJ, Codogno P. Autophagy and p70S6 kinase. Autophagy. 2005;1(1):59–60.View ArticlePubMedGoogle Scholar
- Frykberg RG, Banks J. Challenges in the treatment of chronic wounds. Adv Wound Care (New Rochelle). 2015;4(9):560–82.View ArticlePubMedPubMed CentralGoogle Scholar
- Stappenbeck TS, Miyoshi H. The role of stromal stem cells in tissue regeneration and wound repair. Science. 2009;324(5935):1666–9.View ArticlePubMedGoogle Scholar
- Wan J, Xia L, Liang W, Liu Y, Cai Q. Transplantation of bone marrow-derived mesenchymal stem cells promotes delayed wound healing in diabetic rats. J Diabetes Res. 2013;2013:1–11.View ArticleGoogle Scholar
- Navone SE, Pascucci L, Dossena M, Ferri A, Invernici G, Acerbi F, Cristini S, Bedini G, Tosetti V, Ceserani V, Bonomi A, Pessina A, Freddi G, Alessandrino A, Ceccarelli P, Campanella R, Marfia G, Alessandri G, Parati EA. Decellularized silk fibroin scaffold primed with adipose mesenchymal stromal cells improves wound healing in diabetic mice. Stem Cell Res Ther. 2014;5(1):7.View ArticlePubMedPubMed CentralGoogle Scholar
- Ma D, Kua JE, Lim WK, Lee ST, Chua AW. In vitro characterization of human hair follicle dermal sheath mesenchymal stromal cells and their potential in enhancing diabetic wound healing. Cytotherapy. 2015;17(8):1036–51.View ArticlePubMedGoogle Scholar
- Shrestha C, Zhao L, Chen K, He H, Mo Z. Enhanced healing of diabetic wound by subcutaneous administration of human umbilical cord derived stem cells and their conditioned media. Int J Endocrinol. 2013;2013:1–10.Google Scholar
- Fong CY, Tam K, Cheyyatraivendran S, Gan SU, Gauthaman K, Armugam A, Jeyaseelan K, Choolani M, Biswas A, Bongso A. Human Wharton’s jelly stem cells and its conditioned medium enhance healing of excisional and diabetic wounds. J Cell Biochem. 2014;115(2):290–302.View ArticlePubMedGoogle Scholar
- Xiao M, Li L, Hu Q, Liu L, Chu W, Zhang H. Rapamycin reduces burn wound progression by enhancing autophagy in deep second-degree burn in rats. Wound Repair Regen. 2013;21(6):852–9.View ArticlePubMedGoogle Scholar
- Xie K, Tian L, Guo X, Li K, Li J, Deng X, Li Q, Xia Q, Zhong Y, Huang Z, Liu J, Li S, Yang W, Cao Y. BmATG5 and BmATG6 mediate apoptosis following autophagy induced by 20-hydroxyecdysone or starvation. Autophagy. 2016;12(2):381–96.View ArticlePubMedPubMed CentralGoogle Scholar
- Levine B, Mizushima N, Virgin HW. Autophagy in immunity and inflammation. Nature. 2011;469(7330):323–35.View ArticlePubMedPubMed CentralGoogle Scholar
- Han YF, Sun TJ, Han YQ, Xu G, Liu J, Tao R. Clinical perspectives on mesenchymal stem cells promoting wound healing in diabetes mellitus patients by inducing autophagy. Eur Rev Med Pharmacol Sci. 2015;19(14):2666–70.PubMedGoogle Scholar
- Chen W, Wu Y, Li L, Yang M, Shen L, Liu G, Tan J, Zeng W, Zhu C. Adenosine accelerates the healing of diabetic ischemic ulcers by improving autophagy of endothelial progenitor cells grown on a biomaterial. Sci Rep. 2015;5:11594.View ArticlePubMedPubMed CentralGoogle Scholar
- Jung J, Choi JH, Lee Y, Park JW, Oh IH, Hwang SG, Kim KS, Kim GJ. Human placenta-derived mesenchymal stem cells promote hepatic regeneration in CCl4-injured rat liver model via increased autophagic mechanism. Stem Cells. 2013;31(8):1584–96.View ArticlePubMedGoogle Scholar
- Zhou Z, You Z. Mesenchymal stem cells alleviate LPS-induced acute lung injury in mice by MiR-142a-5p-controlled pulmonary endothelial cell autophagy. Cell Physiol Biochem. 2016;38(1):258–66.View ArticlePubMedGoogle Scholar
- Zhao K, Hao H, Liu J, Tong C, Cheng Y, Xie Z, Zang L, Mu Y, Han W. Bone marrow-derived mesenchymal stem cells ameliorate chronic high glucose-induced β-cell injury through modulation of autophagy. Cell Death Dis. 2015;6(e1885):1–13.Google Scholar
- Shin JY, Park HJ, Kim HN, Oh SH, Bae JS, Ha HJ, Lee PH. Mesenchymal stem cells enhance autophagy and increase β-amyloid clearance in Alzheimer disease models. Autophagy. 2014;10(1):32–44.View ArticlePubMedPubMed CentralGoogle Scholar
- Wang K, Liu R, Li J, Mao J, Lei Y, Wu J, Zeng J, Zhang T, Wu H, Chen L, Huang C, Wei Y. Quercetin induces protective autophagy in gastric cancer cells: involvement of Akt-mTOR and hypoxia-induced factor 1ɑ-mediated signaling. Autophagy. 2011;7(9):966–78.View ArticlePubMedGoogle Scholar
- Andrikopoulou E, Zhang X, Sebastian R, Marti G, Liu L, Milner SM, Harmon JW. Current insights into the role of HIF-1 in cutaneous wound healing. Curr Mol Med. 2011;11(3):218–35.View ArticlePubMedGoogle Scholar
- Arno AI, Amini-Nik S, Blit PH, Al-Shehab M, Belo C, Herer E, Tien CH, Jeschke MG. Human Wharton’s jelly mesenchymal stem cells promote skin wound healing through paracrine signaling. Stem Cell Res Ther. 2014;5(1):28–40.View ArticlePubMedPubMed CentralGoogle Scholar